(Total Views: 656)
Posted On: 02/17/2022 5:53:22 PM
Post# of 145247
In the middle of a buyout scenario putting the patents at risk would be vetoed by the buyout partner. Even in a partnership it could give the potential partner leverage for worse terms for Cytodyn. So long without putting the IP at risk and that's the first thing the new management does.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)